Thompson C, Lucier G W
Mol Pharmacol. 1983 Jul;24(1):69-76.
In addition to estrogen receptors, liver contains a second class of estrogen-binding proteins referred to as higher-capacity, lower-affinity (HCLA) binding sites which are distinct from estrogen receptors. HCLA sites comprise two classes of proteins: moderate-affinity (KD = 0.45 microM and 0.24 microM) estrogen-binding sites unique to male cytosol and a low-affinity, nonsaturable estrogen-binding site present in both sexes. The sex differences observed in HCLA sites are apparently a consequence of imprinting by testicular androgen during a critical neonatal period. Neonatal castration causes a reduction in the concentration of HCLA sites in the subsequent adult male. Furthermore, the moderate-affinity sites detected by Scatchard analysis in adult male liver are not observed in neonatal castrates. Cell-free nuclear translocation assays demonstrate that nuclear uptake of cytosolic receptor-ligand complexes is more efficient in females than in males. This sex difference in nuclear uptake can be minimized when the concentration of the ligand is increased to a level necessary to saturate the estrogen receptor in the presence of HCLA sites. Nuclear uptake of receptor-ligand complexes in neonatally castrated males (deficient in HCLA sites) is similar to that seen in adult females. Elevations of serum triglyceride following estradiol exposure have been monitored as an indicator of hepatic responses to estrogen. Our studies have shown that female liver appears more responsive to estrogen exposure than does male liver. While a dose of 20-30 micrograms of estradiol per kilogram of body weight per day was sufficient to produce a 3- to 4-fold increase in the concentration of triglyceride associated with the very low-density lipoprotein fraction in females, a dose of 100 micrograms of estradiol per kilogram of body weight per day was needed to obtain a similar response in males. However, following neonatal castration, estrogen responsiveness in the subsequent adult male rat was similar to that in females, suggesting a role for neonatal androgens in regulating sex differences in the action of hepatic estrogen.
除雌激素受体外,肝脏还含有第二类雌激素结合蛋白,称为高容量、低亲和力(HCLA)结合位点,它们与雌激素受体不同。HCLA位点由两类蛋白质组成:雄性细胞质特有的中等亲和力(KD = 0.45微摩尔和0.24微摩尔)雌激素结合位点,以及两性均存在的低亲和力、不可饱和的雌激素结合位点。在HCLA位点观察到的性别差异显然是关键新生儿期睾丸雄激素印记的结果。新生儿去势会导致随后成年雄性体内HCLA位点浓度降低。此外,在成年雄性肝脏中通过Scatchard分析检测到的中等亲和力位点在新生去势大鼠中未观察到。无细胞核转位试验表明,雌性细胞质受体-配体复合物的核摄取比雄性更有效。当配体浓度增加到在存在HCLA位点的情况下使雌激素受体饱和所需的水平时,这种核摄取的性别差异可以最小化。新生去势雄性(缺乏HCLA位点)中受体-配体复合物的核摄取与成年雌性相似。已监测雌二醇暴露后血清甘油三酯的升高,作为肝脏对雌激素反应的指标。我们的研究表明,雌性肝脏对雌激素暴露的反应似乎比雄性肝脏更敏感。虽然每天每千克体重20 - 30微克的雌二醇剂量足以使雌性极低密度脂蛋白部分相关的甘油三酯浓度增加3至4倍,但雄性需要每天每千克体重100微克的雌二醇剂量才能获得类似的反应。然而,新生去势后,随后成年雄性大鼠的雌激素反应性与雌性相似,表明新生儿雄激素在调节肝脏雌激素作用的性别差异中起作用。